Neogen | NEOG - Equity Capital And Reserves


Neogen reported $2.1B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Avanos Medical USD 782.1M 3.9M Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
Danaher USD 52.95B 415M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Illumina USD 2.68B 47M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Utah Medical Products USD 119.27M 1.02M Dec/2025
Zoetis USD 3.23B 98M Mar/2026